Joel Greenblatt's CHE Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 48,693 shares of Chemed Corporation (CHE) worth $18.39 M, representing 0.06% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in CHE, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2013, adding 93,804 shares. Largest reduction occurred in Q4 2014, reducing 127,262 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Chemed Corporation (CHE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Chemed Corporation (CHE) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -10,477 | Reduce 17.71% | 48,693 | $377.74 |
| Q4 2025 | +16,427 | Add 38.43% | 59,170 | $427.86 |
| Q3 2025 | +32,545 | Add 319.13% | 42,743 | $447.74 |
| Q2 2025 | -4,750 | Reduce 31.78% | 10,198 | $486.93 |
| Q1 2025 | -1,057 | Reduce 6.60% | 14,948 | $615.32 |
| Q4 2024 | -2,125 | Reduce 11.72% | 16,005 | $529.80 |
| Q3 2024 | -1,142 | Reduce 5.93% | 18,130 | $600.97 |
| Q2 2024 | +8,682 | Add 81.98% | 19,272 | $542.58 |
| Q1 2024 | +1,084 | Add 11.40% | 10,590 | $641.93 |
| Q4 2023 | +528 | Add 5.88% | 9,506 | $584.75 |
| Q3 2023 | +2,805 | Add 45.44% | 8,978 | $519.70 |
| Q2 2023 | +2,081 | Add 50.86% | 6,173 | $541.67 |
| Q1 2023 | +1,333 | Add 48.31% | 4,092 | $537.75 |
| Q4 2022 | -1,392 | Reduce 33.53% | 2,759 | $510.43 |
| Q3 2022 | +208 | Add 5.28% | 4,151 | $436.52 |
| Q2 2022 | +1,632 | Add 70.62% | 3,943 | $469.44 |
| Q1 2022 | +1,101 | Add 90.99% | 2,311 | $506.71 |
| Q4 2021 | +626 | Add 107.19% | 1,210 | $528.93 |
| Q3 2021 | +76 | Add 14.96% | 584 | $465.75 |
| Q2 2021 | -627 | Reduce 55.24% | 508 | $474.41 |
| Q1 2021 | +1,135 | New Buy | 1,135 | $459.91 |
| Q1 2019 | -1,057 | Sold Out | 0 | $0.00 |
| Q4 2018 | -3,714 | Reduce 77.85% | 1,057 | $282.88 |
| Q3 2018 | +3,044 | Add 176.26% | 4,771 | $319.64 |
| Q2 2018 | +1,727 | New Buy | 1,727 | $321.95 |
| Q4 2017 | -18,034 | Sold Out | 0 | $0.00 |
| Q3 2017 | -13,647 | Reduce 43.08% | 18,034 | $202.06 |
| Q2 2017 | +4,169 | Add 15.15% | 31,681 | $204.54 |
| Q1 2017 | -8,013 | Reduce 22.56% | 27,512 | $182.68 |
| Q4 2016 | -52,299 | Reduce 59.55% | 35,525 | $160.42 |
| Q3 2016 | -19,103 | Reduce 17.87% | 87,824 | $141.07 |
| Q2 2016 | +20,093 | Add 23.14% | 106,927 | $136.31 |
| Q1 2016 | +1,670 | Add 1.96% | 86,834 | $135.45 |
| Q4 2015 | +69,464 | Add 442.45% | 85,164 | $149.81 |
| Q3 2015 | +12,083 | Add 334.06% | 15,700 | $133.44 |
| Q2 2015 | -31,568 | Reduce 89.72% | 3,617 | $131.05 |
| Q1 2015 | +2,484 | Add 7.60% | 35,185 | $119.40 |
| Q4 2014 | -127,262 | Reduce 79.56% | 32,701 | $105.68 |
| Q3 2014 | -41,146 | Reduce 20.46% | 159,963 | $102.90 |
| Q2 2014 | -94,444 | Reduce 31.96% | 201,109 | $93.72 |
| Q1 2014 | +21,329 | Add 7.78% | 295,553 | $89.45 |
| Q4 2013 | +30,697 | Add 12.61% | 274,224 | $76.62 |
| Q3 2013 | +93,804 | Add 62.65% | 243,527 | $71.50 |
| Q2 2013 | +149,723 | Add 0.00% | 149,723 | $72.43 |
Joel Greenblatt's Chemed Corporation Investment FAQs
Joel Greenblatt first purchased Chemed Corporation (CHE) in Q2 2013, acquiring 149,723 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Chemed Corporation (CHE) for 44 quarters since Q2 2013.
Joel Greenblatt's largest addition to Chemed Corporation (CHE) was in Q2 2013, adding 149,723 shares worth $10.84 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 48,693 shares of Chemed Corporation (CHE), valued at approximately $18.39 M.
As of the Q1 2026 filing, Chemed Corporation (CHE) represents approximately 0.06% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Chemed Corporation (CHE) was 295,553 shares, as reported at the end of Q1 2014.